Analysis of Tumor Burden as a Biomarker for Patient Survival with Neuroendocrine Tumor Liver Metastases Undergoing Intra-Arterial Therapies: A Single-Center Retrospective Analysis.
Milena MiszczukJulius ChapiroDuc Do MinhJohanna Maria Mijntje van BreugelSusanne SmolkaIrvin RexhaBruno TegelMingDe LinLynn Jeanette SavicKelvin HongChristos GeorgiadesNariman NezamiPublished in: Cardiovascular and interventional radiology (2022)
The overall tumor diameter, overall tumor area, and enhancing tumor burden are strong prognostic factors of overall survival in patients with neuroendocrine tumor liver metastases undergoing intra-arterial therapies.
Keyphrases